Committed to growth and innovation
Vytrus Biotech is a biotechnology company that develops cosmetic active ingredients from plant stem cell technology at industrial scale.
A technology that saves natural resources
Tons of water saved in 2025 in the production of our actives
Tons of water saved in 2025 in the production of our actives
99
%
Average water consumption saved per KG of ingredient produced
Average water consumption saved per KG of ingredient produced
Share information
This section will provide the reader with further details in the coming weeks.
ACCESS TO BME Growth WEBSITE
Financial data
Find and download Vytrus Biotech financial information
Key documents
Press room
Read latest news about Vytrus Biotech:
20/07/2026
Vytrus Biotech increases its sales by 37% and its net profit by 73% in the first half of 2026
The biotechnology company reaches 10 million euros in year-on-year turnover. The company launched Toleroxyl™ on July 1, the first product of its new recombinant protein platform.
05/05/2026
Vytrus Biotech increases its sales by 41% and its net profit by 81% in the first quarter of 2026
The biotechnology company exceeds 9.25 million euros in year-on-year turnover. The international awards together with the registration of the Exopeptides™ technology reinforce Vytrus' leadership in innovation and protection of its intellectual property.